Purchase Order W81K0019P0409
Award Date 10/1/19
Potential Completion Date 9/30/21
Potential Value $91K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order for $124,815.00 was awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc., a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The contract is for the delivery of SC05 Sulfur Colloid 5 vials/box to support nuclear medicine diagnostic services for active duty personnel and their families within the Military Health System. Pharmalucence, Inc. has been awarded multiple...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical manufacturer. The $17,447 contract is for the delivery of molecular imaging products for nuclear medicine, specifically Pharmalucence's SC05 Sulfur Colloid radiopharmaceutical kits. The contract has no set-aside designation, indicating open competition. Pharmalucence, Inc. is a for-profit, Subchapter S Corporation...
- On August 1, 2024, the Department of Veterans Affairs Veterans Integrated Service Network 16 (VISN 16) awarded a delivery order valued at $1.85 million to Medi-Physics, Inc., operating as GE Healthcare, for the supply of radiopharmaceuticals. This firm fixed-price contract, with an ultimate completion date of November 30, 2024, represents a call order under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries no small business set-aside designation. Performance...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a defense agency, to Medi-Physics, Inc., a subsidiary of General Electric Company that specializes in manufacturing and supplying radiopharmaceuticals, medical isotopes, and diagnostic imaging agents. The $100,000.00 firm fixed-price purchase order is for the provision of radiopharmaceuticals, with a period of performance from October 1, 2015 to September 30, 2016. The contract has no set-aside designation,...
- This is a firm fixed-price contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the provision of radiopharmaceutical products to the U.S. Medical Command, a defense agency. The $149,986.08 contract has an ultimate completion date of September 30, 2015 and does not have a set-aside designation. The contract is a call order under a Blanket Purchase Agreement (BPA), indicating it is part of a larger indefinite delivery vehicle (IDV) contract that allows the...
- This federal contract award is for the supply of radiopharmaceutical products and services to the Defense Health Agency (DHA) and Department of the Army Medical Command by Curium US LLC, a foreign-owned, for-profit manufacturer of nuclear medicine goods. The $22,592.62 firm fixed price purchase order has an ultimate completion date of October 11, 2024. Curium holds two active single award blanket purchase agreements (BPAs) with DHA and the Army Medical Command, valued at $1 million and $8...
- This federal contract award is for radiopharmaceuticals and supplies, with a ceiling value of $100,000.00. The contract was awarded to Medi-Physics, Inc., a subsidiary of General Electric Company, and does not have a small business set-aside designation. Medi-Physics, Inc. is a manufacturer of specialized pharmaceutical products used in nuclear medicine procedures, with a focus on radiopharmaceuticals like DATSCAN (ioflupane I-123) for diagnostic imaging. The contract is a Blanket Purchase...
- This is a firm-fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, a for-profit organization. The contract, with a ceiling value of $978,250.00, is for the supply of F18-florbetapir (NeuraCeq) radiopharmaceutical in single-unit doses to support nuclear medicine diagnostic imaging procedures at VA medical facilities. The contract is structured as a Blanket Purchase Agreement (BPA) call and...
- This is a federal contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Pharm-Corp Of Maine LLC, a division of Pharmalogic Holdings, for the provision of radiopharmaceuticals to the TOGUS ME facility. The contract has a firm fixed price and potential value of $207,542.06, with a completion date of January 22, 2019. The contract was not set aside for any specific business type. As a delivery order contract, this award is likely part of a larger contract...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Pharm-Corp of Maine LLC, a for-profit organization, for the provision of radiopharmaceuticals. The contract has a potential value of $181,212.85 and a completion date of December 30, 2019. The contract does not have a set-aside designation. The place of performance is Augusta, Maine. This contract is likely part of the VA's efforts to provide medical services...